Selectis Health offers business improvement

– Revenue for the first quarter of 2022 increased by more than 75% over the year. –

– Ongoing census and performance improvements to drive Systematic development Through First half of 2022 –

– Christine Luke Appointed As Acting Chief Financial Officer –

– Appointment of the Board of Directors of David Frstenberg Establishes a standing audit committee And strengthens corporate governance. Structure –

Greenwood Village, Colorado, July 11, 2022 (Globe Newsvier) – Selectis Health, Inc. The Occupy GBCS (“Selectis” or “Company”) is introducing business improvements to its latest strategic and practical highlights for the second quarter of 2022.

“While we have not yet been able to report our 2021 financial results, we have continued to make significant improvements in patient portfolios and improve the efficiency of our operations,” said Lance Ballar, CEO of Selectis. “Based on our financial statements, which have not yet been evaluated, our revenue for the first quarter of 2022 has increased by more than 75% year-on-year, continuing our strong growth momentum and showing success.

“As we mentioned earlier, the completion of the 2021 financial statements audit has been delayed by various audit field tests, following which the registration for the first quarter of 2022 10-Q has been delayed. Later, we will continue our regular reporting and communication sessions with our annual shareholders’ meeting, focusing on finalizing our financial statements and keeping them up-to-date on our SEC presentations as soon as possible.

Recent operation Highlights (Q2 2022)

Facility fingerprint

• In December 2021, it was decided to take full control of Warranton and Sparta facilities.
• A.D. The company’s nine facilities in 2022 are fully operational, compared to five owned and controlled facilities by 2020.
• In the second quarter of 2022, the park’s facility was converted into a five-year loan.
• Approved direct Medicaid and Medicare payment approval from Medicaid and Medicaid Services Centers (CMS) for all of the company’s service providers – including newly opened buildings – by the end of the second quarter of 2022.

Counting Growth

• A.D. In the first quarter of 2022, the Warranton census record was reached, with more than 56 patients now living.
• In the second quarter of 2022, more than 25 patients were added to the Park Place Institute.
• More than 40 residents of South Hills Independent Residential Facility. The census is expected to reach full capacity (90 residents) by the end of the first quarter of 2023.

New Hers

• He hired two full-time corporate employers who focused on accelerating the company’s internal hiring program. Selectis plans to eliminate manpower needs by a third party by the end of 2022 and will continue to focus on human resource development.
• He has hired two new facility-level executive directors at Sparta and Park, as well as a nursing director and a marketing director at Park.
• He has hired full-time marketing leaders for independent living and trained nursing institutions in South Hills.

Randy Barker, President of Selectis and COO, commented: “In the first half of 2022, we continue to implement key performance improvements to increase our capacity and patient diversity in portfolios. As we began operations in both Warranton and Sparta in December 2021, we had nine of the 13 owned facilities earlier this year if we had the final CMS license to allow direct Medicaid and Medicare payments in December 2021. We now have full Medicaid and Medicare payment certification for all of our facilities and will continue to work to streamline our patient mix to lead to portfolio-wide profitability.

“In the fourth quarter of 2021 and in the first quarter of 2022, we have pushed for improvements in our census-related institutions, despite the impact on the Omikron diversity. At our Warranton facility, the census reached a record high in the first quarter, and in the second quarter we saw strong growth in the Park Plus facility and the South Hills independent housing facility.

We have worked to expand our facility-level recruitment, staff and leadership teams to support further patient growth and reduce the need for temporary third-party nursing staff. The use of our agency was driven by epidemic-related needs and the shortage of nursing staff throughout our industry, and these high third-party wage increases have increased our operating costs by 2021 and 2022. As we intensify our internal recruitment efforts, our goal is to achieve our goal.

“As we enter the second half of 2022, we will work to further enhance our Business Transformation Strategy and improve the quality of care we provide to our patients and residents. And we look forward to making further improvements as we make further strategic progress.

Christine’s appointment Luke As the interim Chief Financial Officer

When he was elected on March 5, 2022, he appointed Christine Lucas as the company’s interim chief financial officer.

Lucas joined the company in 2021 and has nearly a decade of experience in the health and pharmaceutical industries. Prior to joining Selectis, she joined Neubase Therapeutics, Inc. She served as supervisor, focusing on the preparation and reporting of financial statements and the administration of benefits. Prior to Newbase Therapeutics, Lucas was a Pharmacist ink Accounting and Human Resources Manager. She holds a BS in accounting from San Diego State University, and has served as VP of Activities in Student Accounting.

Baller continued, “Having Christine in our executive team has helped us continue to grow in our strategic initiatives. With a strong financial background and a background in the health industry, she has made a significant contribution to Selectis throughout her time with the company. As we grow further into 2022, we look forward to continuing our work with Christ to further guide our long-term vision.

Appointment of the Board of Directors of David Frstenberg

When he was elected on July 1, 2022, he appointed David Furstenberg as the Board of Directors. Furstenberg serves on the Company’s Standing Audit Committee and the Audit Committee is qualified to be a financial expert, as stated in Article 401 (h) of SK.

Furstenberg Tax Lawyer and Certified Public Accountant with more than 35 years of experience in tax research and planning, accounting, state and federal tax returns and audit relations. From 1997 to 2016, he served as director of taxation at Pulte Group, overseeing federal, state, and international tax research. Prior to playing for Pulte Group, Furstenberg served as Assistant Vice President – Tax, Director. Director of Taxation and Federal Taxation by Handelman Company. He has also served as an associate attorney at Price Waterhouse, with Levine, Levine, Garvet & Dill, PC and Tax Consultant and Tax Assistant. Furstenberg holds a BA in Accounting from Michigan State University and a JD from Wayne State University Law School.

Baller concludes: “David brings a wealth of experience in accounting, law and public finance, and experience to our board at a critical juncture in our business transformation. His appointment will enable us to establish our Standing Audit Committees, which will work to strengthen our financial control and enterprise management structure. We look forward to using David’s knowledge as we work to advance our development goals and establish Selectis as a high quality healthcare provider in the South Central and Southeast US.

In Care Of Select Health
Celix Health owns and operates health care facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide range of services, including speech, occupational, physical therapy, social services, and other rehabilitation and health care services. Selectis focuses on building strategic relationships with local communities that will improve partnerships and care for the institution’s residents. With its focus on growth, Celix plans to strengthen its presence in the South Central and Southeast American markets and provide better care for the elderly.

For more information, please visit www.selectis.com.

Future Statements

This press release contains statements that plan for the future. In this press release, future statements are generally identified by the words “expect”, “plan”, “believe”, “expect”, “guess” and so on. These forthcoming statements include the following, but are not limited to

Although we believe that any statements in the future are reasonable in this press release, there are reasons why future statements may differ from what is stated or stated, as future statements may contain concerns and doubts about the future. For example, in addition to the special circumstances described in this press release, some of the uncertainties that may affect the accuracy of future statements include the following:

Investment Relationship
Scott Leolius or Jackie Kesner
Gateway Group, Inc.
(949) 574-3860
selectis@gatewayir.com